Connect Biopharma Holdings Ltd
CNTB · Pharmaceutical Preparations · 63.0M shares · +0%/yr ↑ dilution · EDGAR filings ↗
Reference price $2.48 · est. market cap ~$156M — last insider purchase, 2026-05-29 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D42Clinical/early-stage biotech — immunology clinical, funded.
Strengths
- Liquidity — current ratio 3.7 (49th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Net lossNet loss (net margin -86687.5%)
- Cash burnNegative free cash flow (-51.6M)
- Insider buyingInsider buying — 2 open-market buy(s) by 1 insider(s) (~$4M, last 6mo) Form 4 ↗
- Revenue declineRevenue -99.8% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Operating margin
-90740.6%
Net margin
-86687.5%
Return on equity
-132.2%
Return on assets
-98.9%
Revenue growth (QoQ)
-99.8%
Current ratio
3.7×
Free cash flow
-$52M
EBITDA
-$57M
Tangible book value
$42M
Cash & investments
$44M
Cash runway
3q
Stock comp / revenue
5821.9%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-29 | Huang James | Buy | 150K | $2.48 |
| 2026-03-31 | Xanthopoulos Kleanthis Gabriel | Grant | 2.8K | — |
| 2026-03-31 | LIU JEAN I | Grant | 5.1K | — |
| 2026-03-31 | Huang James | Buy | 1.2M | $3.45 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-12 | ResultsExhibits | filing ↗ |
| 2026-04-23 | Reg FDOtherExhibits | filing ↗ |
| 2026-03-31 | ResultsExhibits | filing ↗ |
| 2026-03-30 | Material agreement3.02Reg FDOtherExhibits | filing ↗ |
| 2025-12-23 | Exec/director changeExhibits | filing ↗ |
| 2025-11-12 | ResultsExhibits | filing ↗ |
| 2025-09-16 | Reg FD | filing ↗ |
| 2025-08-13 | ResultsExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 10-Q | 2026-05-12 | 2026-03-31 | 0001835268-26-000020 ↗ |
| 8-K | 2026-05-12 | 2026-05-12 | 0001835268-26-000019 ↗ |
| 8-K | 2026-04-23 | 2026-04-23 | 0001835268-26-000016 ↗ |
| 8-K | 2026-03-31 | 2026-03-31 | 0001835268-26-000012 ↗ |
| 10-K | 2026-03-31 | 2025-12-31 | 0001835268-26-000013 ↗ |
| 8-K | 2026-03-30 | 2026-03-29 | 0001835268-26-000006 ↗ |
| 8-K | 2025-12-23 | 2025-12-17 | 0001835268-25-000061 ↗ |
| 10-Q | 2025-11-12 | 2025-09-30 | 0001835268-25-000058 ↗ |
| 8-K | 2025-11-12 | 2025-11-12 | 0001835268-25-000057 ↗ |
| 8-K | 2025-09-16 | 2025-09-16 | 0001835268-25-000056 ↗ |
| 10-Q | 2025-08-13 | 2025-06-30 | 0001835268-25-000052 ↗ |
| 8-K | 2025-08-13 | 2025-08-13 | 0001835268-25-000051 ↗ |